Abstract
Purpose
To estimate health utility derived from the Short Form-36 (SF-36) questionnaire and Standard Gamble instrument for persons diagnosed and treated for tuberculosis (TB) disease, those diagnosed and treated for latent TB infection (LTBI), and those screened but not treated for TB disease or LTBI over the year following their diagnosis/initial assessment.
Methods
Participants were recruited at two Montreal hospitals (2008–2011) and completed the SF-36 and Standard Gamble at baseline and at follow-up visits 1, 2, 4, 6, 9, and 12 months thereafter. SF-6D health utility scores were derived from SF-36 responses. Linear mixed models were used to compare mean health utility at each evaluation and changes in health utility between participants treated for TB disease, those treated for LTBI, and those in the control group.
Results
Of the 263 participants, 48 were treated for TB disease, 105 for LTBI, and 110 were control participants. Fifty-four percent were women, mean age was 35 years, and 90 % were foreign-born. Participants treated for TB disease reported worse health utility compared with control participants at the baseline visit (mean SF-6D: 0.69 vs. 0.81; mean Standard Gamble: 0.64 vs. 0.96). They reported successive improvement at months 1 and 2 that was then sustained throughout follow-up. Health utility reported by participants treated for LTBI and control participants was comparable throughout the study.
Conclusion
Treatment for TB disease had a substantial negative impact on health utility, particularly during the first 2 months of treatment. However, treatment for LTBI did not have a substantial impact.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bauer, M., Leavens, A., & Schwartzman, K. (2012). A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life. Quality of Life Research, 21(10), 1727–1730.
Tuberculosis Coalition for Technical Assistance. (2006). International standards for tuberculosis care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance.
Public Health Agency of Canada, Canadian Thoracic Society, and the Canadian Lung Association. (2013). Canadian tuberculosis standards (7th ed.) www.respiratoryguidelines.ca/tb-standard-2013
Menzies, D., Long, R., Trajman, A., Dion, M. J., Yang, J., Al Jahdali, H., et al. (2008). Adverse events with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: Results of a randomized trial. Annals of Internal Medicine, 149, 689–697.
Linas, B. P., Wong, A. Y., Freedberg, K. A., & Horsburgh, C. R, Jr. (2011). Priorities for screening and treatment of latent Tuberculosis infection in the United States. American Journal of Respiratory and Critical Care Medicine, 184(5), 590–601.
Vissandjée, B., Bates, K., Vialla, F., & Kuntz, J. (2013). Expérience d’immigration et droit à la santé, à des soins et à des services de qualité: une question de justice sociale. Revue Internationale de la Recherche Interculturelle Alterstice, 3(1), 67–83.
Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 Physical and Mental Health Summary Scales: A user’s manual. Boston: The Health Institute.
Rossi, C., Zwerling, A., Thibert, L., Rivest, P., McIntosh, F., Behr, M. A., et al. (2012). Mycobacterium tuberculosis transmission over an 11-year period in a low-incidence, urban setting. International Journal of Tuberculosis and Lung Disease, 16, 312–318.
Brazier, J., & Roberts, J. R. (2004). The estimation of a preference-based index from the SF-12. Medical Care, 42(9), 851–859.
Brazier, J., Roberts, J. R., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.
Dion, M. J., Tousignant, P., Bourbeau, J., Menzies, D., & Schwartzman, K. (2004). Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Quality of Life Research, 13, 653–665.
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddard, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). New York: Oxford University Press.
Dion, M. J., Tousignant, P., Bourbeau, J., Menzies, D., & Schwartzman, K. (2002). Measurement of health preferences among patients with tuberculosis infection and disease. Medical Decision Making, 22(Suppl), S102–S114.
Fisher, R. A. (1925). Statistical methods for research workers. Edinburgh: Oliver & Boyd.
Pearson, K. (1900). On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philosophical magazine series 5. doi: 10.1080/14786440009463897
Student, (1908). The probable error of a mean. Biometrika, 6(1), 1–25.
Sloane, J., & Symonds, T. (2001). Health related quality of life: When does a statistically significant change become clinically significant?. Washington, DC: ISOQOL Educational Workshop.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillside, NJ, USA: Academic Press.
Singer, J. D., & Willett, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press.
SAS Institute Inc., SAS statistical software v. 9.3. (2011). Cary, NC, USA.
Microsoft. Microsoft Excel. (2010). Washington, USA: Redmond.
Guo, N., Marra, C. A., Marra, F., Moadebi, S., Elwood, R. K., & Fitzgerald, J. M. (2008). Health state utilities in latent and active tuberculosis. Value in Health, 11(7), 1154–1161.
Kruijshaar, M. E., Lipman, M., Essink-Bot, M.-L., Lozewicz, S., Créer, D., Dart, S., et al. (2010). Health status of UK patients with active tuberculosis. The International Journal of Tuberculosis and Lung Disease, 14(3), 296–302.
Hays, R. D., Reeve, B. B., Smith, A. W., & Clauser, S. B. (2013). Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries. Quality of Life Research. 10.1007/s11136-013-0503-9
Simich, L. (2009). Health literacy and immigrant populations (policy brief). http://canada.metropolis.net/pdfs/health_literacy_policy_brief_jun15_e.pdf
Menzies, D., Oxlade, O., & Lewis, M. (2006). Costs for tuberculosis care in Canada. Public Health Agency of Canada publications and educational materials. 1–28.
Khanna, D., Yan, X., Tashkin, D. P., Furst, D. E., Elashoff, R., Roth, M. D., et al. (2007). Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: Results from the Scleroderma Lung Study. Arthritis and Rheumatism, 56, 1676–1684.
McDonald, J. F., & Moffitt, R. A. (1980). The uses of tobit analysis. The Review of Economics and Statistics,. doi:10.2307/1924766.
Twisk, J., & Rijmen, F. (2009). Longitudinal tobit regression: A new approach to analyze outcome variables with floor or ceiling effects. Journal of Clinical Epidemiology, 62, 953–958.
Von Hippel, P. T. (2007). Regression with missing ys: An improved strategy for analyzing multiple imputed data. Sociological Methodology,. doi:10.1111/j.1467-9531.2007.00180.x.
Acknowledgments
This research was funded by the Canadian Institutes of Health Research (CIHR). M. Bauer was supported by the CIHR-Quebec Respiratory Health Training Program, the Research Institute of the McGill University Health Centre, and the Faculty of Medicine, McGill University.
Conflict of interest
The authors do not have any competing interests to declare.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bauer, M., Ahmed, S., Benedetti, A. et al. The impact of tuberculosis on health utility: a longitudinal cohort study. Qual Life Res 24, 1337–1349 (2015). https://doi.org/10.1007/s11136-014-0858-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-014-0858-6